BIRC5 and cancer: Taken together these data suggest that, in addition to other suggested celecoxib targets such as survivin, the ER stress response and PDK1, CDH11 may play a role in mediating the COX-2 independent effects of the CelebrexTM family of anti-inflammatories in cancer and in RA [42;44].